Order results by:
| Issue | Title | |
| Vol 10, No 2 (2018) | Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. N. Gromov | ||
| "... . Conclusion. The findings indicate that there are molecular mechanisms of synergism between glucosamine ..." | ||
| Vol 11, No 1 (2019) | Molecular mechanisms of myoprotective action of chondroitin sulfate and glucosamine sulfate in sarcopenia | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, N. A. Shostak, K. V. Rudakov | ||
| "... and to justify the use of chondroitin sulfate (CS) and glucosamine sulfate (GS) in these patients. The molecular ..." | ||
| Vol 12, No 2 (2020) | Systematic analysis of the molecular pathophysiology of tenosynovitis: promise for using chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. M. Lila, O. A. Limanova | ||
| "... The chondroprotectors glucosamine sulfate (GS) and chondroitin sulfate (CS) show a complex anti ..." | ||
| Vol 14, No 6 (2022) | On the use of chondroitin sulfate, glucosamine sulfate and undenatured type II collagen for back and limb pain and osteoarthritis | Abstract similar documents |
| O. A. Gromova, I. Y. Torshin, A. M. Lila | ||
| "... of cartilage (chondroprotection), will be symptomatic. The chondroprotective effects of glucosamine sulfate (GS ..." | ||
| Vol 14, No 4 (2022) | Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views | Abstract similar documents |
| O. A. Shavlovskaya, I. V. Sarvilina, O. A. Gromova, M. N. Sharov, I. A. Bokova, Y. S. Prokofieva, N. I. Shavlovskiy | ||
| "... ), glucosamine sulfate (GS), avocado and soy unsaponifiable compounds, diacerein, hyaluronic acid ..." | ||
| Vol 11, No 3 (2019) | On the neurological roles of chondroitin sulfate and glucosamine sulfate: a systematic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, V. A. Semenov, L. I. Stakhovskaya, K. V. Rudakov | ||
| "... Chondroitin sulfate (CS) and glucosamine sulfate (GS) are widely used as chondroprotectors. Data ..." | ||
| Vol 12, No 6 (2020) | A new look at back pain treatment in light of the latest ESCEO guidelines | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Zolotovskaya, Yu. A. Prokofyeva | ||
| "... . The use of glucosamine sulfate (GS) is recommended for patients over 60 years of age. According ..." | ||
| Vol 4, No 2 (2012) | Artra is a model of combination symptom-modifying therapy for osteoarthrosis and intervertebral osteochondrosis | Abstract similar documents |
| V V Badokin | ||
| "... , particularly structural analogues of the cartilage (glucosamine and chondroitin sulfate), that have ..." | ||
| Vol 13, No 4 (2021) | Toll-like receptors as a part of osteoarthritis pathophysiology: anti-inflammatory, analgesic and neuroprotective effects | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. M. Lila, L. I. Alekseeva, E. A. Taskina | ||
| Vol 15, No 2 (2023) | New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council | Abstract similar documents |
| Al. B. Danilov, A. M. Lila, Yo. N. Majidova, O. A. Gromova, O. N. Tkacheva, I. V. Sarvilina, A. Yu. Kochish, A. G. Nazarenko, N. V. Zagorodniy, T. B. Minasov, L. I. Alekseeva, E. A. Taskina, Yu. V. Kotovskaya, E. N. Dudinskaya, A. V. Rozanov, E. Yu. Solovieva, O. A. Shavlovskaya, M. N. Sharov, P. R. Kamchatnov, A. P. Rachin, E. R. Barantsevich, D. A. Iskra, E. Z. Yakupov, F. I. Devlikamova, A. E. Barulin, M. V. Nesterova, T. G. Sakovets, A. N. Barinov, I. N. Dolgova, N. V. Zabolotskikh, E. V. Zonova, L. A. Shchepankevich, V. A. Parfenov, A. T. Dzhurabekova, S. Z. Khakimova | ||
| "... drugs, DMOADs): chondroitin sulfate, glucosamine sulfate, undenatured type II collagen for adjuvant ..." | ||
| Vol 15, No 4 (2023) | Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity | Abstract similar documents |
| O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| "... sulfate and glucosamine sulfate) as well as NK-II, will make it possible to influence the key sites ..." | ||
| Vol 15, No 1 (2023) | Chondroprotectors as modulators of neuroinflammation | Abstract similar documents |
| I. Y. Torshin, O. A. Gromova, A. G. Nazarenko | ||
| "... – CS; glucosamine sulfate – GS) can be useful in the treatment of neuroinflammation and so-called ..." | ||
| Vol 9, No 3 (2017) | Molecular effects of chondroguard in osteoarthritis and herniated discs | Abstract similar documents |
| A. M. Lila, O. A. Gromova, I. Yu. Torshin, A. G. Nazarenko, A. Yu. Gogolev | ||
| "... the molecular-physiological mechanisms of action of CS in intervertebral disc extrusions and protrusions. ..." | ||
| Vol 14, No 5 (2022) | On the role of glycogen synthase kinases in the molecular mechanisms of stress conditions and prospects for the use of lithium ascorbate | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, O. A. Limanova | ||
| Vol 13, No 1 (2021) | Systematic analysis of molecular biological mechanisms for supporting connective tissue metabolism with chondroitin sulfate | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, G. I. Nechaeva, I. A. Reier, N. V. Zagorodniy | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Genetics of Epilepsy: What for and How to Examine Children with Epilepsy E.D. Belousova | Abstract similar documents |
| E. D. Belousova | ||
| "... of monogenic epilepsies in children are described; clinical and research justification of molecular-genetic ..." | ||
| Vol 12, No 5 (2020) | Chemotranscriptome analysis of the ethylmethylhydroxypyridine succinate molecule in the context of postgenomic pharmacology | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. I. Sorokin, V. A. Semenov, L. V. Stakhovskaya | ||
| Vol 9, No 1 (2017) | The triple synergy of ethylmethylhydroxypyridine succinate, magnesium, and vitamin B6: Molecular mechanisms | Abstract similar documents |
| O. A. Gromova, A. G. Kalacheva, I. Yu. Torshin, T. R. Grishina, I. K. Tomilova | ||
| "... analysis of the molecular mechanisms of the triple synergic action of EMHPS, magnesium, and vitamin B6 ..." | ||
| Vol 7, No 4 (2015) | Neurotrophic and antioxidant potential of neuropeptides and trace elements | Abstract similar documents |
| O. A. Gromova, A. V. Pronin, I. Yu. Torshin, A. G. Kalacheva, T. R. Grishina | ||
| "... . The review considers the results of the most recent molecular pharmacological investigations ..." | ||
| No 1S (2016): | Molecular mechanisms responsible for the impact of antiepileptic therapy on bone mineral density of epileptic patients | Abstract similar documents |
| I. A. Zhidkova, T. V. Kaznacheeva, E. Yu. Demidova, V. V. Berseneva | ||
| "... risk for lower bone mineral density. Nevertheless, the molecular mechanisms of action of different AEDs ..." | ||
| Vol 15, No 3 (2023) | Molecular mechanisms of synergistic analgesic and neuroprotective action of B group vitamins according to the results of proteomic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin | ||
| "... functions of which are somehow related to the metabolism of B group vitamins and the molecular ..." | ||
| Vol 15, No 2 (2023) | Clinical course and diagnosis of cerebral vein and sinus thrombosis associated with COVID-19 in young and middle-aged patients | Abstract similar documents |
| E. G. Klocheva, V. V. Goldobin, F. Z. Olimova | ||
| "... of laboratory examination, neuroimaging, and the data of molecular genetic analysis of risk factors ..." | ||
| Vol 5, No 4 (2013) | A case of Niemann – Pick disease type C | Abstract similar documents |
| Sergei Anatolyevich Klyushnikov, O R Smirnov, E Yu Zakharova | ||
| "... diagnostic verification, including molecular genetic testing, are presented. Information is given on specific ..." | ||
| Vol 8, No 3 (2016) | A clinical case of adult onset Niemann–Pick disease type C | Abstract similar documents |
| E. V. Saifullina, R. V. Magzhanov, A. K. Mardanova, T. Yu. Proshlyakova, E. Yu. Zakharova, S. A. Klyushnikov, S. N. Illarioshkin | ||
| Vol 13, No 2 (2021) | Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) | Abstract similar documents |
| M. V. Putilina, N. V. Teplova, O. A. Gromova, I. Yu. Torshin, M. Yu. Maksimova, Yu. S. Prokofieva | ||
| "... micronutrients, which include highly purified forms of chondroitin sulfate and glucosamine sulfate, which have ..." | ||
| Vol 14, No 2 (2022) | Post-COVID pain syndrome: a review of international observations | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Bokova, N. I. Shavlovskiy | ||
| "... of pharmaceutically standardized drugs – chondroitin sulfate (CS) and glucosamine sulfate (GS) are preferred. GS ..." | ||
| Vol 9, No 4 (2017) | Geriatric information analysis of the molecular properties of mexidole | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, L. E. Fedotova | ||
| Vol 9, No 2 (2017) | Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, L. V. Stakhovskaya, L. E. Fedotova | ||
| "... that thiamine disulfide can inhibit the molecular receptors involved in blood pressure regulation: adrenoceptors ..." | ||
| Vol 8, No 2 (2016) | Neuroimmunological mechanisms of chronic pain syndrome | Abstract similar documents |
| I. A. Vyshlova, S. M. Karpov, A. I. Starodubtsev | ||
| "... syndrome. The role of cellular and molecular changes in the posterior horn and in the somatosensory ..." | ||
| Vol 10, No 4 (2018) | Chemoreactome analysis of tolperisone, tizanidine, and baclofen molecules: anticholinergic, antispasmodic, and analgesic mechanisms of action | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov | ||
| "... Muscle relaxants are used in the treatment of musculoskeletal pain. The exact molecular mechanisms ..." | ||
| Vol 9, No 1 (2017) | The genetic basis of Parkinson's disease | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova | ||
| "... as in a patient's death before the onset of the disease. Active introduction of molecular genetic methods ..." | ||
| Vol 5, No 3 (2013) | Prevention of venous thromboembolic events in ischemic stroke | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... , and therapeutic gymnastics. The use of unfractionated heparin (UFH) and low-molecular-weight heparins (LMWH ..." | ||
| Vol 12, No 6 (2020) | Contemporary views of the mechanisms for development of myofascial pain syndrome and its treatment strategies | Abstract similar documents |
| G. R. Tabeeva, E. A. Kiryanova | ||
| "... the molecular mechanisms of trigger point formation and dysregulation of specific skeletal muscle proteins ..." | ||
| Vol 7, No 3 (2015) | Hereditary cerebellar ataxias with polyneuropathy | Abstract similar documents |
| Svetlana Vasilyevna Kopishinskaya | ||
| "... by molecular genetic testing. In recent years, some genetic diseases manifesting themselves by a concurrence ..." | ||
| Vol 9, No 4 (2017) | Neurological complications of alcoholism | Abstract similar documents |
| I. I. Nikiforov, M. M. Rakitin, A. G. Merkin, P. V. Aronov, G. P. Kostyuk, D. V. Savelyev, R. N. Isaev, A. V. Kazantsev, V. A. Priyatel, I. A. Nikiforov | ||
| "... the classification, clinical variants, biochemical and molecular biological aspects of various complications ..." | ||
| Vol 8, No 3 (2016) | Chemoreactome analysis of ethylmethylhydroxypyridine succinate | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, L. E. Fedotova, A. N. Gromov | ||
| "... complete information about its molecular mechanisms of action. Objective: to comparatively analyze ..." | ||
| Vol 8, No 4 (2016) | INTERMEDIATE PHENOTYPES OF OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME | Abstract similar documents |
| N. A. Shnayder, M. M. Petrova, I. V. Demko, O. V. Alekseeva | ||
| "... to the development of four major phenotypes of OSAHS. It characterizes two basic approaches to a molecular genetic ..." | ||
| Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Mental disorders in Huntington’s disease | Abstract similar documents |
| S. A. Klyushnikov, E. N. Yudina, S. N. Illarioshkin, I. A. Ivanova-Smolenskaya | ||
| "... mechanisms in terms of recent advances in molecular biology. The neuropsychiatric manifestations of HD, which ..." | ||
| Vol 4, No 1 (2012) | Association of the dopamine receptor (DRD4, DAT) gene polymorphisms with vital exhaustion in an open population among 25—64-year-old men (Novosibirsk): Epidemiological study according to the WHO MONICA-psychosocial program | Abstract similar documents |
| Valery Vasilyevich Gafarov, M I Voyevoda, E A Gromova, V N Maksimov, A V Gafarova, I V Gagulin, N S Yudin, T M Mishakova | ||
| "... in the Laboratory of Molecular Genetic Studies, Therapy Research Institute, Siberian Branch, Russian Academy ..." | ||
| Vol 13, No 2 (2021) | Chemoreactom analysis of cytidyldiphosphocholine indicates synergistic combinations of neuroprotective agents | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. A. Mayorova, T. R. Grishina, L. E. Fedotova, A. N. Gromov, I. S. Sardaryan | ||
| "... Objective: to establish the molecular mechanisms of interaction of cytidine-diphosphocholine ..." | ||
| Vol 14, No 5 (2022) | Association of affective disorders and MTHFR, MTR, and MTRR gene polymorphisms: preliminary results of a family study | Abstract PDF (Eng) similar documents |
| E. D. Kasyanov, T. V. Zhilyaeva, G. E. Maso | ||
| "... diseases. Further highquality family studies using molecular genetic methods are needed. ..." | ||
| Vol 8, No 2 (2016) | Effect of cerebrolysin on motor function restoration during medical rehabilitation | Abstract similar documents |
| M. A. Kustova, A. P. Tolmachev, N. A. Shamalov | ||
| "... aimed to correct one biochemical or molecular stage of ischemic cell injury fails to treat stroke ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Reduced expression of the tumor necrosis factor gene in blood mononuclear cells in radiologically isolated syndrome – validation of transcriptome analysis results | Abstract similar documents |
| M. S. Kozin, N. M. Baulina, I. S. Kiselev, A. R. Kabaeva, A. N. Boyko, O. O. Favorova, O. G. Kulakova | ||
| "... to RIS, the number of works aimed at studying the molecular mechanisms underlying its formation is very ..." | ||
| Vol 8, No 4 (2016) | MexiB 6 AS A RESULT OF FORTIFICATION OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE WITH MAGNESIUM AND PYRIDOXINE: PROTEOME EFFECTS | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. G. Kalacheva, V. A. Semenov, K. V. Rudakov | ||
| "... : to analyze the biological effects of pyridoxineand magnesium-dependent proteins providing the molecular ..." | ||
| Vol 17, No 3 (2025) | Structure of the subarachnoid lymphatic-like membrane as a meningeal selective barrier and immunological regulator | Abstract similar documents |
| V. N. Nikolenko, M. V. Oganesyan, K. I. Urazmetova, N. A. Rizaeva, M. V. Sankova, А. V. Moiseeva, A. A. Moiseenko, A. A. Belichenko, A. T. Nikitina, L. A. Gridin | ||
| "... The subarachnoid lymphatic-like membrane (SLYM), identified through neuroimaging and molecular ..." | ||
| Vol 10, No 3 (2018) | MicroRNA expression profile in patients in the early stages of ischemic stroke | Abstract similar documents |
| I. S. Zhanin, V. A. Gusar, A. T. Timofeeva, V. G. Pinelis, A. Yu. Asanov | ||
| "... different molecular basis. In addition, it is necessary to take into account gender differences ..." | ||
| Vol 6, No 4 (2014) | The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) | Abstract similar documents |
| M. R. Sapronova, N. A. Shnaider | ||
| "... and 27.4% with new-onset PD; 2) 44 patients (75% of women and 25% of men) with PD who underwent molecular ..." | ||
| Vol 14, No 5 (2022) | Depression and polymorphism G-174C (rs1800795) of the IL-6 gene in an open population of 25–44 year old in Russia/Siberia (WHO international program MONICA-psychosocial) | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, V. N. Maksimov, I. N. Gagulin, A. V. Gafarova | ||
| "... . Genotyping of the studied gene polymorphisms was carried out in the Laboratory of Molecular Genetic Research ..." | ||
| Online-first | Association of carriers of single nucleotide polymorphisms rs1143634 and rs16944 of the Il-1B gene and rs6265 of the BDNF gene with temporal lobe epilepsy | Abstract similar documents |
| Y. S. Panina, D. V. Dmitrenko, N. A. Shnayder, E. V. Egorova, A. A. Usoltseva | ||
| "... epilepsy. Patients and methods. We carried out a molecular genetic study of the carrier of SNPs rs1143634 ..." | ||
| Vol 11, No 2 (2019) | Association of the carriage of IL-1B rs1143634 and rs16944 polymorphisms and BDNF rs6265 polymorphism with temporal lobe epilepsy | Abstract PDF (Eng) similar documents |
| Yu. S. Panina, D. V. Dmitrenko, N. A. Shnaider, E. V. Egorova, A. A. Usoltseva | ||
| "... with the development of TLE. Patients and methods. Real-time polymerase chain reaction was used to conduct a molecular ..." | ||
| Vol 14, No 5 (2022) | Clinical and genetic associations of the CLOCK circadian rhythm gene and depressive disorders in patients with alcohol dependence syndrome during the period of alcohol abstinence | Abstract PDF (Eng) similar documents |
| N. R. Tulbaeva, R. F. Nasyrova, D. A. Smirnova, Z. Sh. Ashurov, I. S. Efremov, V. S. Dobrodeeva, A. E. Abdrakhmanova, A. R. Asadullin | ||
| "... for molecular, genetic and biochemical studies. Results and discussion. Correlations were found between ..." | ||
| Vol 11, No 4 (2019) | Genetic risk factors for behavioral adverse reactions in epileptic patients taking levetiracetam | Abstract similar documents |
| A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder | ||
| "... were divided into four groups according to age and the presence of ADRs. Molecular genetic testing ..." | ||
| Online-first | GENETIC RISK FACTORS FOR THE DEVELOPMENT OF BEHAVIORAL ADVERSE DRUG REACTIONS IN PATIENTS WITH EPILEPSY TAKING LEVETIRACETAM | Abstract similar documents |
| A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder | ||
| "... II, molecular genetic research of SNVs rs1800497 of DRD2 gene (DRD2/ANKK1 Taq1A), rs4680 of COMT gene ..." | ||
| Vol 13, No 4 (2021) | Hereditary neuropathy with liability to pressure palsies: a case report | Abstract similar documents |
| A. K. Polynnikova, O. E. Zinovyeva, O. A. Solokha, E. V. Misyuryaeva | ||
| "... ). Представлено клиническое наблюдение пациента 43 лет с ННСПС, подтвержденной результатами молекулярно ..." | ||
| Vol 5, No 4 (2013) | Venous thromboses and thromboembolism in acute stroke: risk factors, diagnosis, treatment, and prevention | Abstract similar documents |
| Andrei Viktorovich Fonyakin, L A Geraskina | ||
| "... patients, the use of low-molecular-weight heparins (LMWH) reduces the risk of DVT, without increasing ..." | ||
| Vol 13, No 5 (2021) | Anticoagulant therapy for stroke prevention in patients with severe COVID-19 | Abstract similar documents |
| A. T. Azimov, G. S. Rakhimbaeva, F. Z. Azimov | ||
| "... , the prevention of thrombotic complications in patients receiving low-molecular-weight anticoagulants ..." | ||
| Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
| N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
| "... with the advent of siponimod, a new molecular class of S1P receptor modulators. The confirmed efficiency ..." | ||
| Vol 7, No 3 (2015) | Cognitive impairments in common and rare somatic diseases | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... , inflammation and immune disease, molecular sequestration, and cell death. There is enhanced imbalance ..." | ||
| Vol 12, No 5 (2020) | The positive and negative effects of using transdermal nonsteroidal anti-inflammatory drugs: chemoreactome analysis | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, T. R. Grishina, V. A. Semenov | ||
| "... которых молекулярно-фармакологические свойства уже были изучены в экспериментальных и клинических ..." | ||
| Online-first | Association of carriers of single nucleotide polymorphisms rs1143634 and rs16944 in gene Il-1B and rs6265 in gene BDNF with temporal lobe epilepsy | Abstract similar documents |
| Y. S. Panina, D. V. Dmitrenko, N. A. Shnayder, E. V. Egorova, A. A. Usoltseva | ||
| "... BDNF с развитием височной эпилепсии. Пациенты и методы: проведено молекулярно-генетическое ..." | ||
| 1 - 60 of 60 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
